Mca-Ala-Pro-Lys(Dnp)-OH is a dual-labeled fluorescent/quenched peptide designed for protease assays. Its Pro-containing motif influences backbone rigidity, while the modified lysine supports energy-transfer studies. The molecule aids in evaluating catalytic specificity. Applications include enzymatic profiling, fluorescence screening, and mechanism-driven analysis.
CAT No: C0103
CAS No:305336-82-7
Synonyms/Alias:Mca-Ala-Pro-Lys(Dnp)-OH;305336-82-7;L-Lysine, N-[2-(7-methoxy-2-oxo-2H-1-benzopyran-4-yl)acetyl]-L-alanyl-L-prolyl-N6-(2,4-dinitrophenyl)-;Mca-APK(Dnp);HY-P2536;AKOS040758030;DA-65283;FM111000;MS-31157;PD158205;CS-0135080;G17798;Mca-Ala-Pro-Lys(Dnp)-OH trifluoroacetate salt;(2S)-6-(2,4-dinitroanilino)-2-[[(2S)-1-[(2S)-2-[[2-(7-methoxy-2-oxochromen-4-yl)acetyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]hexanoic acid;(2S)-6-[(2,4-DINITROPHENYL)AMINO]-2-{[(2S)-1-[(2S)-2-[2-(7-METHOXY-2-OXOCHROMEN-4-YL)ACETAMIDO]PROPANOYL]PYRROLIDIN-2-YL]FORMAMIDO}HEXANOIC ACID;
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.